Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes

CONTEXT: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) cause less weight loss than expected based on urinary calorie excretion. This may be explained by SGLT2i-induced alterations in central reward and satiety circuits, leading to increased appetite and food intake. Glucagon-like peptide-1 rece...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ruiten, Charlotte C, Veltman, Dick J, Schrantee, Anouk, van Bloemendaal, Liselotte, Barkhof, Frederik, Kramer, Mark H H, Nieuwdorp, Max, IJzerman, Richard G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113812/
https://www.ncbi.nlm.nih.gov/pubmed/35134184
http://dx.doi.org/10.1210/clinem/dgac043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113812/
https://www.ncbi.nlm.nih.gov/pubmed/35134184
http://dx.doi.org/10.1210/clinem/dgac043

Ejemplares similares